Search Results 1601-1610 of 21424 for anti-TNF drugs

1. Study links hyperinflammatory monocytes to FIRES - Mayo Clinic

   Cryptogenic drug-resistant seizure disorders may involve inflammatory processes that traditional anti-seizure medications don't target.

2. Sulfamethoxazole And Trimethoprim (Oral Route) Precautions - Mayo Clinic

   The results of some tests may be affected by this medicine. Patients receiving anticonvulsant treatment (medicines to prevent seizures) may be at risk for a ...

3. Tirzepatide (Subcutaneous Route) Precautions - Mayo Clinic

   Other medicines—Do not take other medicines during the time you are using tirzepatide unless they have been discussed with your doctor. This especially includes ...

4. Estrogen (Oral Route, Parenteral Route, Topical Application Route, Transdermal Route) Proper Use - Mayo Clinic

   Do not allow your pets to lick or touch the arm where the medicine was sprayed. Dosing. The dose medicines in this class will be different for different ...

5. Phentolamine (Injection Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. OraVerse; Regitine. Descriptions. Phentolamine ...

6. Cabotegravir And Rilpivirine (Intramuscular Route) Description and Brand Names - Mayo Clinic

   HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is usually given to patients to replace their current anti-HIV medicines ...

7. Tizanidine (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

8. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... First in Human, Phase I Trial of Anti-CD47 Antibody ZL-1201 in ...

9. Promising developments in the search for glioblastoma therapies - Mayo Clinic

   Mayo Clinic is advancing the search for new glioblastoma treatments. Laboratory studies combining small molecule inhibitors with approved drugs have yielded ...

10. A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer - Mayo Clinic

    Prior use of anti-HER2 therapy for any reason or other prior biologic or immunotherapy for cancer; Concurrent anti-cancer treatment in another investigational ...